BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6105503)

  • 1. Haemolysis and renal impairment syndrome in patients on 5-fluorouracil and mitomycin-C.
    Lempert KD
    Lancet; 1980 Aug; 2(8190):369-70. PubMed ID: 6105503
    [No Abstract]   [Full Text] [Related]  

  • 2. Rash, nephritis, hypertension, and haemolysis in patient on 5-fluorouracil, doxorubicin, and mitomycin-C.
    Karlin DA; Stroehlein JR
    Lancet; 1980 Sep; 2(8193):534-5. PubMed ID: 6105582
    [No Abstract]   [Full Text] [Related]  

  • 3. Microangiopathic hemolytic anemia, noncardiac pulmonary edema, and renal failure after treatment of metastatic adenocarcinoma of the colon with 5-fluorouracil and mitomycin-C: report of a case.
    Claycomb CL; Berkovic M
    J Am Osteopath Assoc; 1986 Aug; 86(8):499-503. PubMed ID: 3093413
    [No Abstract]   [Full Text] [Related]  

  • 4. Microangiopathic hemolytic anemia, renal failure, and noncardiogenic pulmonary edema: a chemotherapy-induced syndrome.
    Jolivet J; Giroux L; Laurin S; Gruber J; Bettez P; Band PR
    Cancer Treat Rep; 1983 May; 67(5):429-34. PubMed ID: 6406059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Three cases of renal failure associated with microangiopathic hemolytic anemia after mitomycin C therapy].
    Hayano K; Fukui H; Otsuka Y; Hattori S
    Nihon Jinzo Gakkai Shi; 1988 Jul; 30(7):835-42. PubMed ID: 3150472
    [No Abstract]   [Full Text] [Related]  

  • 6. [Two cases with microangiopathic hemolytic anemia caused by anti-cancer drugs who improved rapidly after administration of aspirin and dipyridamole].
    Ito S; Hirono S
    Rinsho Ketsueki; 1982 May; 23(5):730-5. PubMed ID: 6813535
    [No Abstract]   [Full Text] [Related]  

  • 7. Pulmonary veno-occlusive disease associated with microangiopathic hemolytic anemia and chemotherapy of gastric adenocarcinoma.
    Waldhorn RE; Tsou E; Smith FP; Kerwin DM
    Med Pediatr Oncol; 1984; 12(6):394-6. PubMed ID: 6548790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversible microangiopathic hemolytic anemia after mitomycin C.
    Perry DJ
    Cancer Chemother Pharmacol; 1983; 10(3):223. PubMed ID: 6407770
    [No Abstract]   [Full Text] [Related]  

  • 9. Haemolytic-uraemic syndrome complicating long-term mitomycin C and 5-fluorouracil therapy for gastric carcinoma.
    Crocker J; Jones EL
    J Clin Pathol; 1983 Jan; 36(1):24-9. PubMed ID: 6401771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Experience of a combination chemotherapy consisting of 5-FU, MMC, and FT-207--side effects against kidney].
    Yamada F; Kagami H; Fukutome A; Mastumine T; Miura T
    Gan To Kagaku Ryoho; 1983 Sep; 10(9):2049-54. PubMed ID: 6412636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal toxicity of mitomycin-C.
    Ravikumar TS; Sibley R; Reed K; Grage TB
    Am J Clin Oncol; 1984 Jun; 7(3):279-85. PubMed ID: 6428215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravascular haemolysis and renal impairment after blood transfusion in two patients on long-term 5-fluorouracil and mitomycin-C.
    Jones BG; Fielding JW; Newman CE; Howell A; Brookes VS
    Lancet; 1980 Jun; 1(8181):1275-7. PubMed ID: 6104085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microangiopathic anemia observed after treatment of epidermoid carcinoma with mitomycin C and 5-fluorouracil.
    Gulati SC; Sordillo P; Kempin S; Reich L; Magill GB; Scheiner E; Clarkson B
    Cancer; 1980 May; 45(9):2252-7. PubMed ID: 7379025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Microangiopathic haemolytic anaemia as a complication of mitomycin C treatment (author's transl)].
    Tigges FJ; Bruntsch U; Groos G; Gallmeier WM
    Dtsch Med Wochenschr; 1982 Jan; 107(4):142-5. PubMed ID: 7056168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [2 cases of aplastic anemia and renal disorders due to mitomycin C].
    Tomura T; Takizawa Y; Irikae K; Korenaga O; Higo O
    Gan No Rinsho; 1966 Mar; 12(3):173-6. PubMed ID: 6010939
    [No Abstract]   [Full Text] [Related]  

  • 16. Renal complications of mitomycin C therapy with special reference to the total dose.
    Valavaara R; Nordman E
    Cancer; 1985 Jan; 55(1):47-50. PubMed ID: 3917353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal failure and hemolytic anemia associated with mitomycin C. A case report.
    Price TM; Murgo AJ; Keveney JJ; Miller-Hardy D; Kasprisin DO
    Cancer; 1985 Jan; 55(1):51-6. PubMed ID: 3917354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemolytic-uremic syndrome in a patient receiving mitomycin C and 5-fluorouracil.
    Willie GR; Levy SM; Michaels RS; Zirkin RM
    Henry Ford Hosp Med J; 1983; 31(2):104-9. PubMed ID: 6313552
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hemolytic-uremic syndrome caused by mitomycin C].
    de Insausti CL; GutiƩrrez LE
    Sangre (Barc); 1988 Aug; 33(4):319-20. PubMed ID: 3142062
    [No Abstract]   [Full Text] [Related]  

  • 20. Pulmonary hypertension, hemolytic anemia, and renal failure. A mitomycin-associated syndrome.
    McCarthy JT; Staats BA
    Chest; 1986 Apr; 89(4):608-11. PubMed ID: 3082608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.